The COVID-19 pandemic presents a challenging contradiction for pharmaceutical marketers: in-person healthcare professional-representative interactions are limited by social distancing measures, but physicians across specialties are still seeking to engage with field forces.Given

The prostate-specific antigen (PSA) score has become a critical post-diagnosis tool for oncologists as they discuss prostate cancer disease state with their patients along with their families and caregivers.Oncologist-patient relationships are based

A return to pre-pandemic levels of in-person promotional activity looks increasingly uncertain in H2 2020. Given this uncertainty, pharmaceutical manufacturers, from diversified, multinational firms to more focused, growth-stage companies are navigating the complexities

Oncology treatment decisions are complex. Managing the patient journey requires careful consideration of a wide range of variables.Oncologists commonly refer to NCCN guidelines and other treatment algorithms to ensure they are providing

Pharmaceutical manufacturers, from diversified, multinational firms to focused, growth-stage companies are adapting to the reality of COVID-19. Recent Q1 investor calls provide insight into both the impact of the pandemic thus far on

With the ASCO 2020 Annual Meeting just days away, oncologists are nearly universally planning to “attend” this year’s virtual meeting. However, their participation in the meeting will be less in real-time and

Since 2018, the migraine treatment landscape has changed dramatically, with two new approvals in the month of February alone (Vyepti, Nurtec ODT). In light of these developments, we were curious about how migraine

As of March 13, the AAN annual meeting has been cancelled due to the ongoing global COVID-19 (Coronavirus) pandemic. We'll be keeping a close eye on any plans to hold events digitally and

While opioid abuse deterrence and deprescribing topics were again center stage at the American Academy of Pain Medicine (AAPM) Annual Meeting this year—held February 26-March 1 in National Harbor, MD—headache and

The continued growth of personalized medicine and other treatment trends presents new challenges for market researchers. Within patient populations that were once considered relatively homogenous, new, smaller patient subgroups are being identified as

Nearly 30,000 hematology specialists gathered for this year’s 2019 American Society of Hematology (ASH) annual meeting held Dec 7-10 in Orlando, Florida. This year’s conference delivered on its promise to

The ASH 2019 Annual Meeting kicks-off this Saturday (12/7) in Orlando. Our survey of 51 practicing hematologists-oncologists indicated a great deal of excitement and anticipation, as they prepare for the meeting.In

Following AHA 2019 Scientific Sessions, Novartis announced its intention to buy The Medicines Company for nearly $10B, based on promising results on its small interfering RNA (siRNA) therapy, inclisiran.The therapy targets PCSK9

This year’s annual meeting held November 8-13 did not disappoint according to a ZoomRx survey with 35 rheumatologists who attended the conference.